Lawson J H, Kalafatis M, Stram S, Mann K G
Department of Biochemistry, University of Vermont, College of Medicine, Burlington 05405-0068.
J Biol Chem. 1994 Sep 16;269(37):23357-66.
The activation of prothrombin, factor V, factor VIII, factor IX, and factor X by the tissue factor-factor VIIa complex, in vitro, in a system in which each precursor protein was present at plasma concentration, was evaluated using a combination of activity assays, immunoblots, active-site blots, and autoradiography. The thrombin generation curves observed were distinctly nonlinear and typically displayed a time lag in which little or no thrombin was observed. This was followed by an almost linear propagation phase of thrombin formation. The lag was a function of tissue factor/factor VIIa concentration and represented primarily the interval of factor V and factor VIII activation. The postlag propagation phase of thrombin generation was nearly independent of the initial activator (factor VIIa or tissue factor) concentration over a 10(3)-fold range in factor VIIa-tissue factor concentration. Maximum thrombin generation rates were observed when less than 1% of the factor IX and X present was activated but when nearly 100% activation of the cofactors, factor V and factor VIII, was achieved. Analyses of the activation pattern of factor V indicated that the cofactor is activated by both factor Xa and thrombin which are formed at low levels during the lag phase of the reaction. When the initial reaction mixture contained factor Va instead of factor V, the lag was substantially reduced. When factor V was deleted from the reaction mixture, no thrombin formation was observed. When either factor VII or factor IX was deleted from the reaction system, the propagation phase of thrombin formation (at 5 pM tissue factor-factor VIIa complex) was only one-third that observed for reactions which contained factor VIII and factor IX. The addition of factor XI to the experimental system increased the rate of thrombin formation by 15% during the propagation phase but had no effect upon the lag phase of the reaction. Our data suggest that normal hemostasis may be initiated by the factor VIIa-tissue factor complex and support the concept of multiple feedback reactions which amplify and propagate the hemostatic response.
在一个每个前体蛋白均以血浆浓度存在的体外系统中,利用活性测定、免疫印迹、活性位点印迹和放射自显影相结合的方法,评估了组织因子 - 因子VIIa复合物对凝血酶原、因子V、因子VIII、因子IX和因子X的激活作用。观察到的凝血酶生成曲线明显呈非线性,通常表现出一个时间滞后,在此期间几乎观察不到凝血酶。随后是凝血酶形成的几乎呈线性的传播阶段。该滞后是组织因子/因子VIIa浓度的函数,主要代表因子V和因子VIII激活的间隔时间。在因子VIIa - 组织因子浓度10³倍的范围内,凝血酶生成的滞后后传播阶段几乎与初始激活剂(因子VIIa或组织因子)浓度无关。当存在的因子IX和X激活不到1%但辅因子因子V和因子VIII几乎100%激活时,观察到最大凝血酶生成速率。对因子V激活模式的分析表明,该辅因子由反应滞后阶段低水平形成的因子Xa和凝血酶激活。当初始反应混合物含有因子Va而不是因子V时,滞后显著减少。当从反应混合物中去除因子V时,未观察到凝血酶形成。当从反应系统中去除因子VII或因子IX时,凝血酶形成的传播阶段(在5 pM组织因子 - 因子VIIa复合物时)仅为含有因子VIII和因子IX的反应所观察到的三分之一。在实验系统中加入因子XI在传播阶段使凝血酶形成速率提高了15%,但对反应的滞后阶段没有影响。我们的数据表明,正常止血可能由因子VIIa - 组织因子复合物启动,并支持多重反馈反应的概念,这些反应放大并传播止血反应。